Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on May 31, 2002; DOI 10.1182/blood-2001-12-0251.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2001-12-0251v1
100/7/2487    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuno, H.
Right arrow Articles by Uematsu, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuno, H.
Right arrow Articles by Uematsu, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted December 14, 2001
Accepted April 11, 2002

Lack of {alpha}2-antiplasmin promotes pulmonary heart failure via over-release of VEGF after acute myocardial infarction

Hiroyuki Matsuno, Osamu Kozawa*, Naoki Yoshimi, Sigeru Akamatsu, Akira Hara, Hideki Mori, Kiyotaka Okada, Sigeru Ueshima, Osamu Matsuo, and Toshihiko Uematsu

Department of Pharmacology, Gifu University School of Medicine, Gifu, Japan; Department of Physiology II, Kinki University School of Medicine, Osakasayama City, Japan
Department of Pharmacology, Gifu University School of Medicine, Gifu, Japan
First Department of Pathology, Ryukyu University School of Medicine, Okinawa, Japan
Department of Critical Care Medicine, Gifu University School of Medicine, Gifu, Japan
First Department of Pathology, Gifu University School of Medicine, Gifu, Japan
Department of Physiology II, Kinki University School of Medicine, Osakasayama City, Japan

* Corresponding author; email: okozawa{at}cc.gifu-u.ac.jp.

Identification of a novel therapy for prevention of sudden death by ischemic cardiac infarction is an area of intensive investigation. We here report that the mortality due to an experimental acute myocardial infarction (AMI) was significantly increased in mice deficient in {alpha}2-antiplasmin ({alpha}2-AP-/- mice), but not in mice deficient in other components acting in fibrinolysis (tPA, uPA or PAI-1) even if the infarct area in {alpha}2-AP-/- mice was not different from those in the other mice. Echocardiography showed in {alpha}2-AP-/- mice after AMI, an over-load of right ventricle and that pulmonary permeability was increased. According to the experiments using explanted myocytes and vascular smooth muscle cells, it was found that the amount of secreted vascular endothelial cell growth factor (VEGF) in {alpha}2-AP-/- mice was significantly increased as compared with that in wild type mice. Finally, an injection of an anti-VEGF antibody decreased the mortality after AMI in {alpha}2-AP-/- mice. Plasmin cleaves extracellular matrix-bound VEGF to release a diffusible proteolytic fragment and is mainly inactivated by {alpha}2-AP. Therefore, lack of {alpha}2-AP could markedly results in over-release of VEGF by the continuous activation of plasmin due to acute myocardial infarction and results in an acute corpulmonale. Our results provide new aspects on the role of {alpha}2-AP and VEGF in the pathogenesis of cardiac events.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Matsuno, H. Tokuda, A. Ishisaki, Y. Zhou, Y. Kitajima, and O. Kozawa
P2Y12 Receptors Play a Significant Role in the Development of Platelet Microaggregation in Patients with Diabetes
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 920 - 927.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Adams, K. Lenk, A. Linke, D. Lenz, S. Erbs, M. Sandri, A. Tarnok, S. Gielen, F. Emmrich, G. Schuler, et al.
Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia
Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 684 - 690.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Matsuno, A. Ishisaki, K. Nakajima, K. Okada, S. Ueshima, O. Matsuo, and O. Kozawa
Lack of {alpha}2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice
Blood, November 15, 2003; 102(10): 3621 - 3628.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
S. Stefansson and D. A. Lawrence
Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration
Sci. Signal., July 1, 2003; 2003(189): pe24 - pe24.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020